IE35461L - Cardenolides and bufadienolides. - Google Patents
Cardenolides and bufadienolides.Info
- Publication number
- IE35461L IE35461L IE710920A IE92071A IE35461L IE 35461 L IE35461 L IE 35461L IE 710920 A IE710920 A IE 710920A IE 92071 A IE92071 A IE 92071A IE 35461 L IE35461 L IE 35461L
- Authority
- IE
- Ireland
- Prior art keywords
- prepared
- compounds
- azido
- epidigoxigenin
- exx
- Prior art date
Links
- 150000001652 bufadienolides Chemical class 0.000 title 1
- 150000001738 cardenolides Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 10
- SHIBSTMRCDJXLN-DYQFMBOASA-N 3-epi-digoxigenin Chemical compound C1([C@@H]2[C@@]3([C@@](CC2)(O)[C@H]2[C@@H]([C@@]4(C)CC[C@@H](O)C[C@H]4CC2)C[C@H]3O)C)=CC(=O)OC1 SHIBSTMRCDJXLN-DYQFMBOASA-N 0.000 abstract 6
- YYROPELSRYBVMQ-UHFFFAOYSA-N 4-toluenesulfonyl chloride Chemical compound CC1=CC=C(S(Cl)(=O)=O)C=C1 YYROPELSRYBVMQ-UHFFFAOYSA-N 0.000 abstract 4
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 abstract 4
- SHRGTLYZJIVTMQ-HAXYUZPQSA-N (5r,10s,13r,14s,17r)-14-hydroxy-10,13-dimethyl-17-(5-oxo-2h-furan-3-yl)-1,2,4,5,6,7,8,9,11,15,16,17-dodecahydrocyclopenta[a]phenanthrene-3,12-dione Chemical compound C1([C@@H]2[C@@]3([C@@](CC2)(O)C2C([C@@]4(C)CCC(=O)C[C@H]4CC2)CC3=O)C)=CC(=O)OC1 SHRGTLYZJIVTMQ-HAXYUZPQSA-N 0.000 abstract 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 3
- QEEBRPGZBVVINN-SIBWXOBNSA-N 5-[(3r,5r,8r,9s,10s,13r,14s,17r)-3,14-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]pyran-2-one Chemical compound C=1([C@H]2CC[C@]3(O)[C@H]4[C@@H]([C@]5(CC[C@@H](O)C[C@H]5CC4)C)CC[C@@]32C)C=CC(=O)OC=1 QEEBRPGZBVVINN-SIBWXOBNSA-N 0.000 abstract 2
- SHIBSTMRCDJXLN-UHFFFAOYSA-N Digoxigenin Natural products C1CC(C2C(C3(C)CCC(O)CC3CC2)CC2O)(O)C2(C)C1C1=CC(=O)OC1 SHIBSTMRCDJXLN-UHFFFAOYSA-N 0.000 abstract 2
- WTDHULULXKLSOZ-UHFFFAOYSA-N Hydroxylamine hydrochloride Chemical compound Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 abstract 2
- -1 N-(2-acetoxyethyl)acetylamino Chemical group 0.000 abstract 2
- 125000001589 carboacyl group Chemical group 0.000 abstract 2
- 238000006243 chemical reaction Methods 0.000 abstract 2
- 229940089960 chloroacetate Drugs 0.000 abstract 2
- QONQRTHLHBTMGP-UHFFFAOYSA-N digitoxigenin Natural products CC12CCC(C3(CCC(O)CC3CC3)C)C3C11OC1CC2C1=CC(=O)OC1 QONQRTHLHBTMGP-UHFFFAOYSA-N 0.000 abstract 2
- SHIBSTMRCDJXLN-KCZCNTNESA-N digoxigenin Chemical compound C1([C@@H]2[C@@]3([C@@](CC2)(O)[C@H]2[C@@H]([C@@]4(C)CC[C@H](O)C[C@H]4CC2)C[C@H]3O)C)=CC(=O)OC1 SHIBSTMRCDJXLN-KCZCNTNESA-N 0.000 abstract 2
- 230000007062 hydrolysis Effects 0.000 abstract 2
- 238000006460 hydrolysis reaction Methods 0.000 abstract 2
- REJBTXQSIQFRRE-UHFFFAOYSA-N odorigenone-B Natural products CC12CCC(C3(CCC(=O)CC3CC3)C)C3C1(O)CCC2C1=CC(=O)OC1 REJBTXQSIQFRRE-UHFFFAOYSA-N 0.000 abstract 2
- YHPFWEDUGHFFTA-UHFFFAOYSA-N (5alpha,14beta)-14-Hydroxy-3-oxobufa-20,22-dienolide Natural products CC12CCC(C3(CCC(=O)CC3CC3)C)C3C1(O)CCC2C=1C=CC(=O)OC=1 YHPFWEDUGHFFTA-UHFFFAOYSA-N 0.000 abstract 1
- 125000004890 (C1-C6) alkylamino group Chemical group 0.000 abstract 1
- 125000006619 (C1-C6) dialkylamino group Chemical group 0.000 abstract 1
- XZTUSOXSLKTKJQ-CTZIAKJASA-N 3-[(3r,5r,8r,9s,10s,13r,14s,17r)-3,14-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2h-furan-5-one Chemical compound C1([C@H]2CC[C@]3(O)[C@H]4[C@@H]([C@]5(CC[C@@H](O)C[C@H]5CC4)C)CC[C@@]32C)=CC(=O)OC1 XZTUSOXSLKTKJQ-CTZIAKJASA-N 0.000 abstract 1
- YHPFWEDUGHFFTA-PNERCMSUSA-N 5-[(5r,8r,9s,10s,13r,14s,17r)-14-hydroxy-10,13-dimethyl-3-oxo-2,4,5,6,7,8,9,11,12,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-17-yl]pyran-2-one Chemical compound C=1([C@H]2CC[C@]3(O)[C@H]4[C@@H]([C@]5(CCC(=O)C[C@H]5CC4)C)CC[C@@]32C)C=CC(=O)OC=1 YHPFWEDUGHFFTA-PNERCMSUSA-N 0.000 abstract 1
- IWCNCUVTGOMGKG-UHFFFAOYSA-N 5alpha-oleandrigenin Natural products CC(=O)OC1CC2(O)C3CCC4CC(O)CCC4(C)C3CCC2(C)C1C1=CC(=O)OC1 IWCNCUVTGOMGKG-UHFFFAOYSA-N 0.000 abstract 1
- 229910000761 Aluminium amalgam Inorganic materials 0.000 abstract 1
- 101000653791 Bos taurus Protein S100-A12 Proteins 0.000 abstract 1
- QEEBRPGZBVVINN-UHFFFAOYSA-N Desacetyl-bufotalin Natural products CC12CCC(C3(CCC(O)CC3CC3)C)C3C1(O)CCC2C=1C=CC(=O)OC=1 QEEBRPGZBVVINN-UHFFFAOYSA-N 0.000 abstract 1
- LTMHDMANZUZIPE-AMTYYWEZSA-N Digoxin Natural products O([C@H]1[C@H](C)O[C@H](O[C@@H]2C[C@@H]3[C@@](C)([C@@H]4[C@H]([C@]5(O)[C@](C)([C@H](O)C4)[C@H](C4=CC(=O)OC4)CC5)CC3)CC2)C[C@@H]1O)[C@H]1O[C@H](C)[C@@H](O[C@H]2O[C@@H](C)[C@H](O)[C@@H](O)C2)[C@@H](O)C1 LTMHDMANZUZIPE-AMTYYWEZSA-N 0.000 abstract 1
- PVAMXWLZJKTXFW-UHFFFAOYSA-N Gitoxigenin Natural products CC12CCC(C3(CCC(O)CC3CC3)C)C3C1(O)CC(O)C2C1=CC(=O)OC1 PVAMXWLZJKTXFW-UHFFFAOYSA-N 0.000 abstract 1
- YGYAWVDWMABLBF-UHFFFAOYSA-N Phosgene Chemical compound ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 abstract 1
- XZTUSOXSLKTKJQ-UHFFFAOYSA-N Uzarigenin Natural products CC12CCC(C3(CCC(O)CC3CC3)C)C3C1(O)CCC2C1=CC(=O)OC1 XZTUSOXSLKTKJQ-UHFFFAOYSA-N 0.000 abstract 1
- 125000005236 alkanoylamino group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 150000001412 amines Chemical class 0.000 abstract 1
- QEEBRPGZBVVINN-BMPKRDENSA-N bufalin Chemical compound C=1([C@H]2CC[C@]3(O)[C@H]4[C@@H]([C@]5(CC[C@H](O)C[C@H]5CC4)C)CC[C@@]32C)C=CC(=O)OC=1 QEEBRPGZBVVINN-BMPKRDENSA-N 0.000 abstract 1
- 125000001951 carbamoylamino group Chemical group C(N)(=O)N* 0.000 abstract 1
- 239000000969 carrier Substances 0.000 abstract 1
- 238000009903 catalytic hydrogenation reaction Methods 0.000 abstract 1
- XZTUSOXSLKTKJQ-CESUGQOBSA-N digitoxigenin Chemical class C1([C@H]2CC[C@]3(O)[C@H]4[C@@H]([C@]5(CC[C@H](O)C[C@H]5CC4)C)CC[C@@]32C)=CC(=O)OC1 XZTUSOXSLKTKJQ-CESUGQOBSA-N 0.000 abstract 1
- LTMHDMANZUZIPE-PUGKRICDSA-N digoxin Chemical compound C1[C@H](O)[C@H](O)[C@@H](C)O[C@H]1O[C@@H]1[C@@H](C)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@@H]3C[C@@H]4[C@]([C@@H]5[C@H]([C@]6(CC[C@@H]([C@@]6(C)[C@H](O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)C[C@@H]2O)C)C[C@@H]1O LTMHDMANZUZIPE-PUGKRICDSA-N 0.000 abstract 1
- 229960005156 digoxin Drugs 0.000 abstract 1
- LTMHDMANZUZIPE-UHFFFAOYSA-N digoxine Natural products C1C(O)C(O)C(C)OC1OC1C(C)OC(OC2C(OC(OC3CC4C(C5C(C6(CCC(C6(C)C(O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)CC2O)C)CC1O LTMHDMANZUZIPE-UHFFFAOYSA-N 0.000 abstract 1
- PVAMXWLZJKTXFW-VQMOFDJESA-N gitoxigenin Chemical class C1([C@H]2[C@@H](O)C[C@]3(O)[C@H]4[C@@H]([C@]5(CC[C@H](O)C[C@H]5CC4)C)CC[C@@]32C)=CC(=O)OC1 PVAMXWLZJKTXFW-VQMOFDJESA-N 0.000 abstract 1
- 230000011987 methylation Effects 0.000 abstract 1
- 238000007069 methylation reaction Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- IWCNCUVTGOMGKG-YOVVEKLRSA-N oleandrigenin Chemical compound C1([C@@H]2[C@@]3(C)CC[C@@H]4[C@@]5(C)CC[C@H](O)C[C@H]5CC[C@H]4[C@@]3(O)C[C@@H]2OC(=O)C)=CC(=O)OC1 IWCNCUVTGOMGKG-YOVVEKLRSA-N 0.000 abstract 1
- 230000003647 oxidation Effects 0.000 abstract 1
- 238000007254 oxidation reaction Methods 0.000 abstract 1
- 150000002923 oximes Chemical class 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000012279 sodium borohydride Substances 0.000 abstract 1
- 229910000033 sodium borohydride Inorganic materials 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J19/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 by a lactone ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
1346350 3-Aminosteroids F HOFFMANNLA ROCHE & CO AG 23 July 1971 [24 July 1970] 34756/71 Heading C2U The invention comprises compounds of formula wherein A signifies a grouping of formula A 1 , A 2 , A 3 , or A 4 wherein R<SP>1</SP> is H, OH or OCOMe; R<SP>2</SP> is OH or OCOMe; R<SP>3</SP> is amino, C 1-6 alkylamino, #- hydroxyethylamino, C 1-6 alkanoylamino, di- (C 1-6 alkyl)amino, di(C 1-6 alkanoyl)amino, N- (C 1-6 alkyl)-N-(C 1-6 alkanoyl)amino, N-(2-acetoxyethyl)acetylamino, pyrrolidino, piperidino, morpholino, 2<SP>1</SP>-oxo-3<SP>1</SP>-oxazolidinyl, or ureido; R<SP>4</SP> is Me; and R<SP>5</SP> is (#-H; alternatively when A is a grouping of Formula A 1 (wherein R<SP>1</SP> is H) then either R<SP>4</SP> may be Me and R<SP>5</SP> is α-H, or R<SP>4</SP> may be CHO, CH 2 OH or CO 2 H and R<SP>5</SP> is #-OH. Preparation of compounds I (wherein R<SP>3</SP>= NH 2 ) is by reduction of the corresponding 3- azido or 3-hydroxyimino compounds, e.g. with aluminium amalgam or by catalytic hydrogenation. Preparation of compounds I (wherein R<SP>3</SP> is other than NH 2 ) is (i) by reacting the corresponding 3-bromo or 3-tosyloxy compounds with an appropriate amine; (ii) by aculation, methylation, hydroxyethylation or carbamoylization of a 3-NH 2 compound; or (iii) by reacting a 3-(#-hydroxyethylamino) compound with phosgene to produce the corresponding 3-(2- oxo-3-oxazolidinyl) compound. The 3 - p - toluenesulphonate and 3 - azido - 3- deoxy derivatives of digitoxigenin, 3-epidigitoxigenin, oleandrigenin, 3-epioleandrigenin, digoxigenin 12-acetate, 3-epidigoxigenin 12-acetate, bufalin and 3-epibufalin, are prepared from said parent compounds by the successive actions of tosyl chloride and sodium azide, the latter reaction involving inversion of configuration at the 3-position. (Ex. 5, 6, 7, 9, 15, 19, 23, 25). The 3α - p - toluenesulphonate and 3# - azido- 3 deoxy derivatives of 3 - epiresibufogenin and of 3-epicinobufagin are prepared from said parent compounds by the successive actions of tosyl chloride and sodium azide (Exx. 33, 34). The 3 - azido - 3 - deoxy derivatives of gitoxigenin and 3-epigitoxigenin are prepared by hydrolysis of the 16-acetates thereof (Exx. 11, 13). 3α - Azido - 3 - deoxydigoxigenin is prepared by hydrolysis of its 12-acetate (Ex. 19). 3# - Azido - 12#,14 - dihydroxy - 5#,14#- card - 20(22) - enolide (XI) is prepared from digoxin (X) by the sequence X # digoxigenin 12 - chloroacetate # digoxigenone 12 - chloroacetate # digoxigenone # digoxigenone 12- formate #3 - epidigoxigenin 12 - formate # 3 - epidigoxigenin # 3 - epidigoxigenin 3- p - toluenesulphonate # 3# - azido - 12#- formyloxy - 14 - hydroxy - 5#,14# - card - 20(22)- enolide # XI (Ex. 17). 3 - Epidigoxigenin 12 - acetate, 3 - epidigoxigenin 12 -formate, 3 - epibufalin, 3 - epiresibufogenin and 3-epicinobufagin are each prepared by sodium borohydride reduction of the corresponding 3-ketones (Exx. 15, 17, 25, 33, 34). Bufalone and uzarigenone are prepared by oxidation of the corresponding 3#-ols using "Kiliani mixture" (Exx. 23, 30). Oximes are prepared from digitoxigenone and uzarigenone by reaction with hydroxylamine hydrochloride (Exx. 1, 30). Compounds of Formula I are said to be cardioactive, and may be made up with carriers into pharmaceutical compositions for oral, parenteral or rectal administration.
[GB1346350A]
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH1123870A CH551962A (en) | 1970-07-24 | 1970-07-24 | PROCESS FOR MANUFACTURING NEW CARDENOLIDS AND BUFADIENOLIDS. |
Publications (2)
Publication Number | Publication Date |
---|---|
IE35461L true IE35461L (en) | 1972-01-24 |
IE35461B1 IE35461B1 (en) | 1976-02-18 |
Family
ID=4371487
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IE920/71A IE35461B1 (en) | 1970-07-24 | 1971-07-20 | Cardenolides and bufadienolides and a process for the manufacture thereof |
Country Status (18)
Country | Link |
---|---|
AR (1) | AR192757A1 (en) |
AT (3) | AT324588B (en) |
BE (1) | BE770401A (en) |
BR (1) | BR7104492D0 (en) |
CA (1) | CA959046A (en) |
CH (2) | CH551962A (en) |
DE (1) | DE2137047A1 (en) |
ES (1) | ES393552A1 (en) |
FI (1) | FI50632C (en) |
FR (1) | FR2100951B1 (en) |
GB (1) | GB1346350A (en) |
HU (1) | HU162587B (en) |
IE (1) | IE35461B1 (en) |
IL (1) | IL37236A (en) |
NL (1) | NL7108804A (en) |
NO (1) | NO136151C (en) |
SE (1) | SE375778B (en) |
ZA (1) | ZA714215B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2415640A1 (en) * | 1978-01-27 | 1979-08-24 | Nativelle Sa Ets | 3-AMINO-CARDENOLIDE DERIVATIVES, PROCESS FOR THEIR PREPARATION, AND MEDICINAL PRODUCTS CONTAINING THEM |
FR2415641A1 (en) * | 1978-01-27 | 1979-08-24 | Nativelle Sa Ets | AMINO-3-CARDENOLIDES, PROCESS FOR THEIR PREPARATION, AND MEDICINAL PRODUCTS CONTAINING THEM |
WO2007081835A2 (en) * | 2006-01-09 | 2007-07-19 | Btg International Limited | Modulators of hypoxia inducible factor-1 and related uses |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1365255A (en) * | 1960-07-05 | 1964-07-03 | Roussel Uclaf | Bis-hydroxymethylene pregnane derivatives and method of preparation |
-
1970
- 1970-07-24 CH CH1123870A patent/CH551962A/en not_active IP Right Cessation
-
1971
- 1971-06-16 FI FI711702A patent/FI50632C/en active
- 1971-06-25 NL NL7108804A patent/NL7108804A/xx unknown
- 1971-06-28 ZA ZA714215A patent/ZA714215B/en unknown
- 1971-06-28 CA CA116,791A patent/CA959046A/en not_active Expired
- 1971-07-05 IL IL37236A patent/IL37236A/en unknown
- 1971-07-15 BR BR4492/71A patent/BR7104492D0/en unknown
- 1971-07-20 IE IE920/71A patent/IE35461B1/en unknown
- 1971-07-22 SE SE7109438A patent/SE375778B/xx unknown
- 1971-07-22 FR FR7126843A patent/FR2100951B1/fr not_active Expired
- 1971-07-23 NO NO2811/71A patent/NO136151C/en unknown
- 1971-07-23 DE DE19712137047 patent/DE2137047A1/en active Pending
- 1971-07-23 AT AT1076972A patent/AT324588B/en not_active IP Right Cessation
- 1971-07-23 GB GB3475671A patent/GB1346350A/en not_active Expired
- 1971-07-23 HU HUHO1398A patent/HU162587B/hu unknown
- 1971-07-23 AT AT1077072A patent/AT322749B/en not_active IP Right Cessation
- 1971-07-23 ES ES393552A patent/ES393552A1/en not_active Expired
- 1971-07-23 AT AT642171A patent/AT307642B/en not_active IP Right Cessation
- 1971-07-23 BE BE770401A patent/BE770401A/en unknown
-
1972
- 1972-04-04 AR AR241287A patent/AR192757A1/en active
-
1975
- 1975-01-13 CH CH1123870A patent/CH565202A5/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
SE375778B (en) | 1975-04-28 |
NL7108804A (en) | 1972-01-26 |
HU162587B (en) | 1973-03-28 |
FR2100951B1 (en) | 1974-10-18 |
BR7104492D0 (en) | 1973-03-08 |
CH551962A (en) | 1974-07-31 |
AT322749B (en) | 1975-06-10 |
IL37236A (en) | 1975-02-10 |
AT324588B (en) | 1975-09-10 |
NO136151B (en) | 1977-04-18 |
AR192757A1 (en) | 1973-03-14 |
BE770401A (en) | 1972-01-24 |
ZA714215B (en) | 1972-03-29 |
AT307642B (en) | 1973-05-25 |
IL37236A0 (en) | 1971-10-20 |
IE35461B1 (en) | 1976-02-18 |
CA959046A (en) | 1974-12-10 |
FI50632B (en) | 1976-02-02 |
GB1346350A (en) | 1974-02-06 |
FI50632C (en) | 1976-05-10 |
NO136151C (en) | 1977-07-27 |
ES393552A1 (en) | 1973-08-16 |
CH565202A5 (en) | 1975-08-15 |
DE2137047A1 (en) | 1972-01-27 |
FR2100951A1 (en) | 1972-03-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IE42704L (en) | Prostaglandin derivatives and their preparation | |
GB1441101A (en) | Reagents for the assay of cardenolide glycosides and aglycones | |
ES450333A1 (en) | Tylosin derivatives and their manufacturing process | |
IE35461L (en) | Cardenolides and bufadienolides. | |
GB1147801A (en) | Improvements in or relating to novel steroids and the manufacture thereof | |
GB1450807A (en) | Cardenolide glycosides and process for their manufacture | |
GB1510841A (en) | Derivatives of 11-hydroxytestosterone processes for preparing them and uses for them | |
GB1425607A (en) | Impression composition | |
KR960703940A (en) | 15,15-Dialkyl-Substituted Derivatives of Estradiol | |
GB1492746A (en) | Androstane derivatives and compositions containing them | |
GB1342272A (en) | 3-amino-cardenolides and process for their manufacture | |
GB1512236A (en) | Thiophene derivatives and process for their manufacture | |
GB1299650A (en) | O-(nitroaryl)oximes of 3-keto steroids | |
GB1461051A (en) | Bufatrienolide rhamnoside ethers and a process for their preparation | |
GB1164067A (en) | Acetals and Ketals of 3beta-(&alpha-L-rhamnosido)-04beta-hydroxy-19-oxo(or-hydroxy)-bufa-4,20,22-trienolides | |
IE36592L (en) | Pregnane derivatives. | |
GB1378605A (en) | Derivatives of dihydrodigoxin | |
GB1244560A (en) | Halogenated steroids and process for the manufacture thereof | |
GB1145336A (en) | 17--[3' furyl]-estrogens and process for the preparation thereof | |
GB1429951A (en) | O-nitroaryl-oximes of 3-keto steroids | |
GB1185381A (en) | 05,16beta-Methylene Steroids of the 19-Nor-Androstane Series and Process for their Manufacture | |
GB1529249A (en) | 21-acetals and mixed acetals of steroidal 21-aldehydes intermediates and methods of preparation | |
GB1278445A (en) | Estrogenic agents and preparation of same | |
IE42058L (en) | Quaternary salts of d-homosteroids | |
GB1363674A (en) | Cardenolide derivatives and a process for their manufacture |